BOLD Capital Partners is a venture capital firm based in Santa Monica that focuses on exponential technologies and life sciences. The firm typically backs companies developing transformative approaches across health, deep tech, and advanced scientific domains.

Its strategy is rooted in the belief that biological and digital technologies will increasingly converge, making it relevant for neurotech, longevity, and complex medical platform companies. BOLD is not a pure neurotech specialist, but it is relevant for companies positioned around large scientific or technological shifts.

The firm primarily invests in North America, with selective global reach. Its importance lies in supporting ambitious, technically differentiated startups that require both significant capital and alignment with long-horizon innovation themes.